Eqvista Pricing Overview

Yes. According to G2 data, Eqvista offers a free plan with limited features. Users can upgrade to paid plans for additional capabilities. Visit the seller's official pricing page to compare plan options and features.

Pricing details for Eqvista are not publicly listed. Users should visit the Eqvista's official pricing page or contact the vendor directly for current pricing information.

Eqvista's pricing is best suited for startups and small businesses seeking professional equity management without enterprise-level costs. G2 reviewers from small businesses across technology, marketing, healthcare, and consulting industries consistently praise Eqvista's freemium and Premium tiers for eliminating spreadsheet risk at accessible price points. Mid-market companies in computer software and financial services gravitate toward Eqvista's 409A Valuation and Enterprise tiers, valuing integrated NACVA-certified valuations and compliance tools. G2 data on Eqvista also shows strong adoption among advisors and investors managing multiple portfolio companies. The pricing of Eqvista scales well from pre-funded startups needing basic cap table hygiene to Series A and beyond companies requiring full compliance infrastructure.

Eqvista's free Freemium tier supports fewer than 20 stakeholders and covers core cap table and ESOP management, vesting schedules, stakeholder accounts, and a data room, with no credit card required. Eqvista's paid Premium plan, priced at $2 per month per stakeholder, unlocks e-signing, board resolutions, 83(b) elections, ASC 718, waterfall and funding round modeling, and spreadsheet import. G2 reviewers frequently highlight round modeling and waterfall analysis as standout capabilities driving upgrades. Eqvista's 409A Valuation and Enterprise tiers add NACVA-certified valuations starting at $990 per year, QSBS attestation, and unlimited valuation updates, features G2 users describe as critical for audit readiness and investor confidence.

G2 reviewers overwhelmingly rate Eqvista at 5.0 out of 5, with many explicitly citing strong cost-to-value ratios. A CFO reviewer noted Eqvista delivers 90% of enterprise functionality at 10% of the cost, saving over $12,000 annually compared to traditional 409A valuation firms. A healthcare co-founder mentioned being quoted over $8,000 by traditional firms before choosing Eqvista at a fraction of the cost. G2 reviews of Eqvista also highlight 25 to 30 percent reductions in administrative overhead as recurring benefits. The one pricing concern noted by some G2 reviewers is that Eqvista's pricing can feel like a stretch for very early-stage, pre-revenue bootstrapped startups with minimal equity complexity.